XML 37 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) (USD $)
In Millions, unless otherwise specified
Sep. 26, 2014
Sep. 27, 2013
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Mar. 19, 2014
Cadence Pharmaceuticals, Inc.
Oct. 01, 2012
CNS Therapeutics, Inc.
Sep. 26, 2014
Specialty Pharmaceuticals
Sep. 27, 2013
Specialty Pharmaceuticals
Oct. 01, 2012
Specialty Pharmaceuticals
CNS Therapeutics, Inc.
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]                
Cash     $ 445.1 $ 43.2       $ 3.6
Inventory     67.9 21.0        
Intangible assets     5,601.1 1,300.0       91.9
Goodwill (non-tax deductible) 2,401.9 532.0 1,771.5 318.1   2,401.9 312.3 24.5
Other assets, current and non-current     273.9 18.0       9.7
Total assets acquired     8,159.5 1,700.3       129.7
Current liabilities     159.8 60.1       4.0
Unpaid purchase consideration (current)     128.8          
Other liabilities (non-current)     183.7 18.7        
Deferred tax liabilities, net (non-current)     1,900.7 292.3       27.1
Contingent consideration (non-current)     0 0 6.9     6.9
Total liabilities assumed     2,373.0 371.1       38.0
Net assets acquired     $ 5,786.5 $ 1,329.2       $ 91.7